Antitussive Use in Patients with Inadequately Controlled Moderate-to-Severe Asthma: A Post Hoc Analysis of the Omalizumab EXTRA Trial

Onyinye I Iweala2 Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, NC, USA

Kyle Anders3 Genentech, Inc., South San Francisco, CA, USAView further author information

Jinnie Ko3 Genentech, Inc., South San Francisco, CA, USAView further author information

Parul Mital3 Genentech, Inc., South San Francisco, CA, USAView further author information

Sachin Gupta3 Genentech, Inc., South San Francisco, CA, USACorrespondence[email protected]
View further author information

Arjun Mohan4 Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USAView further author information

Your download is now in progress and you may close this window